Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eight Weeks of Low Dose hCG Priming in Women With Diminished Ovarian Reserve Undergoing IVF/ICSI
NCT07108621Phase 3Recruiting
- Start
- Jan 2026
- Primary completion
- Mar 2028
- Modality
- rProtein (Recombinant Protein), Hormone, Biologic
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Diminished Ovarian Reserve (DOR) (2 arms). Primary endpoint: Number of oocytes retrieved at 4 months. Started Jan 2026; status: recruiting.
02
Conditions
Diminished Ovarian Reserve (DOR)
Beyond the preview
Go deeper on NCT07108621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07108621.